Cohesion CE-marks its CoStasis surgical hemostat:
This article was originally published in Clinica
Palo Alto, California-based Cohesion Technologies has CE-marked its CoStasis Surgical Hemostat. The product consists of thrombin, collagen and autologous fibrinogen, and is designed to control diffuse bleeding during surgical procedures. It is used in a spray form to allow delivery over large or more detailed surface areas. CoStasis remains intact while the wound heals and is then absorbed and eliminated by the body. The patient's own plasma is used in the product, which reduces occurrence of disease transmission.